| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Mapping the antigenic and genetic evolution of influenza virus.
|
Science
|
2004
|
14.28
|
|
2
|
Airborne transmission of influenza A/H5N1 virus between ferrets.
|
Science
|
2012
|
13.48
|
|
3
|
Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome.
|
Proc Natl Acad Sci U S A
|
2004
|
12.39
|
|
4
|
Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls.
|
J Virol
|
2005
|
10.77
|
|
5
|
The global circulation of seasonal influenza A (H3N2) viruses.
|
Science
|
2008
|
10.05
|
|
6
|
Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets.
|
Science
|
2009
|
7.80
|
|
7
|
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome.
|
Lancet
|
2003
|
6.52
|
|
8
|
H5N1 Virus Attachment to Lower Respiratory Tract.
|
Science
|
2006
|
6.34
|
|
9
|
Spatial, temporal, and species variation in prevalence of influenza A viruses in wild migratory birds.
|
PLoS Pathog
|
2007
|
6.04
|
|
10
|
Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals.
|
Am J Pathol
|
2007
|
4.86
|
|
11
|
Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells.
|
J Exp Med
|
2008
|
3.97
|
|
12
|
Host species barriers to influenza virus infections.
|
Science
|
2006
|
3.94
|
|
13
|
Virology: SARS virus infection of cats and ferrets.
|
Nature
|
2003
|
3.86
|
|
14
|
Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution.
|
Science
|
2013
|
3.38
|
|
15
|
Design and use of conditional MHC class I ligands.
|
Nat Med
|
2006
|
3.01
|
|
16
|
Mallards and highly pathogenic avian influenza ancestral viruses, northern Europe.
|
Emerg Infect Dis
|
2005
|
2.90
|
|
17
|
Severity of pneumonia due to new H1N1 influenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus.
|
J Infect Dis
|
2010
|
2.81
|
|
18
|
The molecular basis of the pathogenicity of the Dutch highly pathogenic human influenza A H7N7 viruses.
|
J Infect Dis
|
2007
|
2.58
|
|
19
|
Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses.
|
Vaccine
|
2008
|
2.56
|
|
20
|
Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments.
|
Virus Res
|
2004
|
2.43
|
|
21
|
Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques.
|
Nat Med
|
2004
|
2.31
|
|
22
|
In vitro assessment of attachment pattern and replication efficiency of H5N1 influenza A viruses with altered receptor specificity.
|
J Virol
|
2010
|
2.23
|
|
23
|
Yearly influenza vaccinations: a double-edged sword?
|
Lancet Infect Dis
|
2009
|
2.22
|
|
24
|
Introduction of virulence markers in PB2 of pandemic swine-origin influenza virus does not result in enhanced virulence or transmission.
|
J Virol
|
2010
|
2.19
|
|
25
|
Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding.
|
J Virol
|
2010
|
2.17
|
|
26
|
Limited airborne transmission of H7N9 influenza A virus between ferrets.
|
Nature
|
2013
|
2.17
|
|
27
|
Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice.
|
J Exp Med
|
2009
|
2.12
|
|
28
|
Population dynamics of rapid fixation in cytotoxic T lymphocyte escape mutants of influenza A.
|
Proc Natl Acad Sci U S A
|
2003
|
2.03
|
|
29
|
Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host.
|
J Virol
|
2009
|
1.99
|
|
30
|
Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes.
|
J Immunol
|
2004
|
1.87
|
|
31
|
Practical considerations for high-throughput influenza A virus surveillance studies of wild birds by use of molecular diagnostic tests.
|
J Clin Microbiol
|
2008
|
1.85
|
|
32
|
Influenza vaccination in children with asthma: randomized double-blind placebo-controlled trial.
|
Am J Respir Crit Care Med
|
2003
|
1.81
|
|
33
|
Seasonal and pandemic human influenza viruses attach better to human upper respiratory tract epithelium than avian influenza viruses.
|
Am J Pathol
|
2010
|
1.81
|
|
34
|
Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
|
J Virol
|
2005
|
1.64
|
|
35
|
Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses.
|
Proc Natl Acad Sci U S A
|
2010
|
1.63
|
|
36
|
Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets.
|
J Virol
|
2010
|
1.55
|
|
37
|
Animal models for the preclinical evaluation of candidate influenza vaccines.
|
Expert Rev Vaccines
|
2010
|
1.51
|
|
38
|
Newer respiratory virus infections: human metapneumovirus, avian influenza virus, and human coronaviruses.
|
Curr Opin Infect Dis
|
2005
|
1.46
|
|
39
|
Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus.
|
PLoS One
|
2009
|
1.44
|
|
40
|
Pathogenesis of Influenza A/H5N1 virus infection in ferrets differs between intranasal and intratracheal routes of inoculation.
|
Am J Pathol
|
2011
|
1.44
|
|
41
|
The multibasic cleavage site in H5N1 virus is critical for systemic spread along the olfactory and hematogenous routes in ferrets.
|
J Virol
|
2012
|
1.40
|
|
42
|
Induction of humoral and cellular immune responses by antigen-expressing immunostimulatory liposomes.
|
J Control Release
|
2012
|
1.39
|
|
43
|
Rapid sequencing of the non-coding regions of influenza A virus.
|
J Virol Methods
|
2006
|
1.35
|
|
44
|
Possible increased pathogenicity of pandemic (H1N1) 2009 influenza virus upon reassortment.
|
Emerg Infect Dis
|
2011
|
1.31
|
|
45
|
Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza A (H3N2) virus is mediated by virus-specific T-cells.
|
J Gen Virol
|
2011
|
1.29
|
|
46
|
Annexin II incorporated into influenza virus particles supports virus replication by converting plasminogen into plasmin.
|
J Virol
|
2008
|
1.23
|
|
47
|
Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus.
|
J Virol
|
2013
|
1.22
|
|
48
|
Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.
|
J Infect Dis
|
2007
|
1.18
|
|
49
|
Annual vaccination against influenza virus hampers development of virus-specific CD8⁺ T cell immunity in children.
|
J Virol
|
2011
|
1.16
|
|
50
|
Response to 2009 pandemic influenza A (H1N1) vaccine in HIV-infected patients and the influence of prior seasonal influenza vaccination.
|
PLoS One
|
2011
|
1.15
|
|
51
|
A reverse-genetics system for Influenza A virus using T7 RNA polymerase.
|
J Gen Virol
|
2007
|
1.14
|
|
52
|
Genomewide analysis of reassortment and evolution of human influenza A(H3N2) viruses circulating between 1968 and 2011.
|
J Virol
|
2013
|
1.13
|
|
53
|
Induction of virus-specific cytotoxic T lymphocytes as a basis for the development of broadly protective influenza vaccines.
|
J Biomed Biotechnol
|
2011
|
1.13
|
|
54
|
Highly pathogenic avian influenza virus H7N7 isolated from a fatal human case causes respiratory disease in cats but does not spread systemically.
|
Am J Pathol
|
2010
|
1.12
|
|
55
|
Lack of CD200 enhances pathological T cell responses during influenza infection.
|
J Immunol
|
2009
|
1.11
|
|
56
|
Insertion of a multibasic cleavage motif into the hemagglutinin of a low-pathogenic avian influenza H6N1 virus induces a highly pathogenic phenotype.
|
J Virol
|
2010
|
1.11
|
|
57
|
Recurring influenza B virus infections in seals.
|
Emerg Infect Dis
|
2013
|
1.09
|
|
58
|
Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice.
|
J Gen Virol
|
2010
|
1.09
|
|
59
|
The hypervariable immunodominant NP418-426 epitope from the influenza A virus nucleoprotein is recognized by cytotoxic T lymphocytes with high functional avidity.
|
J Virol
|
2006
|
1.09
|
|
60
|
Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus.
|
Vaccine
|
2007
|
1.09
|
|
61
|
Preferential HLA usage in the influenza virus-specific CTL response.
|
J Immunol
|
2004
|
1.08
|
|
62
|
Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control.
|
Hum Vaccin
|
2009
|
1.07
|
|
63
|
Profiling of humoral response to influenza A(H1N1)pdm09 infection and vaccination measured by a protein microarray in persons with and without history of seasonal vaccination.
|
PLoS One
|
2013
|
1.07
|
|
64
|
Evasion of influenza A viruses from innate and adaptive immune responses.
|
Viruses
|
2012
|
1.06
|
|
65
|
FATT-CTL assay for detection of antigen-specific cell-mediated cytotoxicity.
|
Cytometry A
|
2008
|
1.05
|
|
66
|
DC-SIGN enhances infection of cells with glycosylated West Nile virus in vitro and virus replication in human dendritic cells induces production of IFN-alpha and TNF-alpha.
|
Virus Res
|
2008
|
1.05
|
|
67
|
Fluorescent antigen-transfected target cell cytotoxic T lymphocyte assay for ex vivo detection of antigen-specific cell-mediated cytotoxicity.
|
J Infect Dis
|
2005
|
1.04
|
|
68
|
Both conventional and interferon killer dendritic cells have antigen-presenting capacity during influenza virus infection.
|
PLoS One
|
2009
|
1.02
|
|
69
|
Evidence for specific packaging of the influenza A virus genome from conditionally defective virus particles lacking a polymerase gene.
|
Vaccine
|
2006
|
1.01
|
|
70
|
Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice.
|
Blood
|
2012
|
1.01
|
|
71
|
Highly pathogenic avian influenza virus (H5N1) infection in red foxes fed infected bird carcasses.
|
Emerg Infect Dis
|
2008
|
1.00
|
|
72
|
Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis.
|
PLoS Pathog
|
2013
|
1.00
|
|
73
|
PAR1 contributes to influenza A virus pathogenicity in mice.
|
J Clin Invest
|
2012
|
1.00
|
|
74
|
Efficacy of vaccination with different combinations of MF59-adjuvanted and nonadjuvanted seasonal and pandemic influenza vaccines against pandemic H1N1 (2009) influenza virus infection in ferrets.
|
J Virol
|
2011
|
0.97
|
|
75
|
Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses.
|
J Gen Virol
|
2012
|
0.95
|
|
76
|
MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization.
|
PLoS One
|
2009
|
0.95
|
|
77
|
An amino acid substitution in the influenza A virus hemagglutinin associated with escape from recognition by human virus-specific CD4+ T-cells.
|
Virus Res
|
2007
|
0.95
|
|
78
|
Annual influenza vaccination affects the development of heterosubtypic immunity.
|
Vaccine
|
2012
|
0.94
|
|
79
|
Insertion of a multibasic cleavage site in the haemagglutinin of human influenza H3N2 virus does not increase pathogenicity in ferrets.
|
J Gen Virol
|
2011
|
0.93
|
|
80
|
Genetic evolution of the neuraminidase of influenza A (H3N2) viruses from 1968 to 2009 and its correspondence to haemagglutinin evolution.
|
J Gen Virol
|
2012
|
0.92
|
|
81
|
Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H1N1 vaccine in the ferret model.
|
J Gen Virol
|
2010
|
0.91
|
|
82
|
Reassortment between Avian H5N1 and human influenza viruses is mainly restricted to the matrix and neuraminidase gene segments.
|
PLoS One
|
2013
|
0.89
|
|
83
|
A recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virus.
|
PLoS One
|
2011
|
0.88
|
|
84
|
Plasminogen promotes influenza A virus replication through an annexin 2-dependent pathway in the absence of neuraminidase.
|
J Gen Virol
|
2010
|
0.87
|
|
85
|
Avian influenza a virus in wild birds in highly urbanized areas.
|
PLoS One
|
2012
|
0.86
|
|
86
|
Low attack rate of novel influenza A (H1N1) virus infection among healthcare workers: a prospective study in a setting with an elaborated containment plan.
|
Int Arch Occup Environ Health
|
2011
|
0.84
|
|
87
|
Assessment of the antiviral properties of recombinant porcine SP-D against various influenza A viruses in vitro.
|
PLoS One
|
2011
|
0.84
|
|
88
|
Effect of travel on influenza epidemiology.
|
Emerg Infect Dis
|
2013
|
0.83
|
|
89
|
Infection of the upper respiratory tract with seasonal influenza A(H3N2) virus induces protective immunity in ferrets against infection with A(H1N1)pdm09 virus after intranasal, but not intratracheal, inoculation.
|
J Virol
|
2013
|
0.83
|
|
90
|
Binding of DC-SIGN to the hemagglutinin of influenza A viruses supports virus replication in DC-SIGN expressing cells.
|
PLoS One
|
2013
|
0.83
|
|
91
|
The number and position of N-linked glycosylation sites in the hemagglutinin determine differential recognition of seasonal and 2009 pandemic H1N1 influenza virus by porcine surfactant protein D.
|
Virus Res
|
2012
|
0.83
|
|
92
|
Targets for the induction of protective immunity against influenza a viruses.
|
Viruses
|
2010
|
0.82
|
|
93
|
In vitro assessment of the immunological significance of a human monoclonal antibody directed to the influenza a virus nucleoprotein.
|
Clin Vaccine Immunol
|
2013
|
0.82
|
|
94
|
Influenza virus vaccination induces interleukin-12/23 receptor beta 1 (IL-12/23R beta 1)-independent production of gamma interferon (IFN-gamma) and humoral immunity in patients with genetic deficiencies in IL-12/23R beta 1 or IFN-gamma receptor I.
|
Clin Vaccine Immunol
|
2008
|
0.81
|
|
95
|
Perigranuloma localization and abnormal maturation of B cells: emerging key players in sarcoidosis?
|
Am J Respir Crit Care Med
|
2012
|
0.80
|
|
96
|
Selective expansion of influenza A virus-specific T cells in symptomatic human carotid artery atherosclerotic plaques.
|
Stroke
|
2007
|
0.79
|
|
97
|
Pulmonary surfactant protein D in first-line innate defence against influenza A virus infections.
|
J Innate Immun
|
2013
|
0.79
|
|
98
|
Intrahost evolution of envelope glycoprotein and OrfA sequences after experimental infection of cats with a molecular clone and a biological isolate of feline immunodeficiency virus.
|
Virus Res
|
2008
|
0.79
|
|
99
|
Pediatric influenza vaccination: understanding the T-cell response.
|
Expert Rev Vaccines
|
2012
|
0.79
|
|
100
|
Influenza A(H1N1) Oseltamivir Resistant Viruses in the Netherlands During the Winter 2007/2008.
|
Open Virol J
|
2011
|
0.78
|
|
101
|
The influence of influenza virus infections on the development of tuberculosis.
|
Tuberculosis (Edinb)
|
2013
|
0.78
|
|
102
|
Does influenza vaccination exacerbate asthma in children?
|
Vaccine
|
2004
|
0.78
|
|
103
|
Induction of influenza (H5N8) antibodies by modified vaccinia virus Ankara H5N1 vaccine.
|
Emerg Infect Dis
|
2015
|
0.78
|
|
104
|
Antibodies specific for hypervariable regions 3 to 5 of the feline immunodeficiency virus envelope glycoprotein are not solely responsible for vaccine-induced acceleration of challenge infection in cats.
|
J Gen Virol
|
2004
|
0.78
|
|
105
|
Characterization of recombinant influenza A virus as a vector for HIV-1 p17Gag.
|
Vaccine
|
2009
|
0.78
|
|
106
|
The ins and outs of universal childhood influenza vaccination.
|
Future Microbiol
|
2011
|
0.77
|
|
107
|
Evaluation of vaccination strategies against infection with feline immunodeficiency virus (FIV) based on recombinant viral vectors expressing FIV Rev and OrfA.
|
Vet Immunol Immunopathol
|
2008
|
0.77
|
|
108
|
Mutations, drift, and the influenza archipelago.
|
Discov Med
|
2004
|
0.76
|
|
109
|
Evaluation of ISCOM-adjuvanted subunit vaccines containing recombinant feline immunodeficiency virus Rev, OrfA and envelope protein in cats.
|
Vaccine
|
2008
|
0.76
|
|
110
|
[Influenza vaccination of immunocompromised patients: safe and effective].
|
Ned Tijdschr Geneeskd
|
2009
|
0.75
|
|
111
|
Virus infections: T cells come to the rescue.
|
Curr Opin Virol
|
2013
|
0.75
|